Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Dividends
Dividend Yield
Hubei Biocause Pharmaceutical Co Ltd
Current Yield | |
Min Yield | |
Max Yield | |
Average Yield | |
Median Yield |
Dividend Per Share
Hubei Biocause Pharmaceutical Co Ltd
Payout Ratio
Hubei Biocause Pharmaceutical Co Ltd
Current Payout | |
Min Payout | |
Max Payout | |
Average Payout | |
Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Hubei Biocause Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Debt Paydown
Not Applicable
Due to the unique financial structures and regulatory environments of banks and insurance companies, the Debt Paydown metric is not applicable for Hubei Biocause Pharmaceutical Co Ltd.
These institutions manage liabilities differently, focusing more on regulatory compliance and operational liabilities than traditional debt management, making standard debt paydown calculations irrelevant.
Price Appreciation
Price
Hubei Biocause Pharmaceutical Co Ltd
Average Annual Return | -15.9% |
Standard Deviation of Annual Returns | 10.21% |
Max Drawdown | -74% |
Market Capitalization | 19.9B CNY |
Shares Outstanding | 4 940 630 000 |
Percentage of Shares Shorted |
N/A
|
Stock Splits
Hubei Biocause Pharmaceutical Co Ltd's latest stock split occurred on Apr 12, 2010
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
The adjusted shares began trading on Apr 12, 2010. This was Hubei Biocause Pharmaceutical Co Ltd's 8th stock split, following the previous one in Nov 9, 2005.